Filter
Sort
ISB, Integrated Diagnostics and Sera Prognostics just announced a paper entitled, “The building blocks of successful translation of proteomics to the clinic,” by Leroy Hood and colleagues published online in Current Opinion in Biotechnology.
Institute for Systems Biology (ISB) is among several organizations conducting a clinical trial testing how health coaching affects the cognitive function of patients with early-stage Alzheimer’s disease and analyzing longitudinal, multi-omic data to explore transitions in cognitive function over time.
Sriharshita Musunuri, 17, is looking to find and stop what causes sepsis, the top killer in American hospitals. She is collaborating with several ISB staff members, including mentor Chris Lausted, and just earned a $25,000 scholarship for her work.
Lee Hood co-founded Institute for Systems Biology in 2000, and has served as president of the institution since; on January 1, 2018, he left that role to serve as chief science officer of Providence St. Joseph Health. Here, Hood shares the many lessons he learned from 17 years at the helm of ISB.
Dead cells, or cell debris, generated by treatments intended to eradicate tumor cells actually act as strong stimulators of tumor progression. The findings of ISB cancer biologist Sui Huang, his former mentee and longtime collaborator Dipak Panigrahy at Beth Isreal Deaconess Medical Center in Boston, and colleagues at Harvard Medical School were published in The Journal of Experimental Medicine.
Once an immunologist focusing on research at ISB, Colleen Sheridan followed her passion and became a tenure-track college biology professor focusing on teaching. Sheridan was awarded the Valerie Logan Leadership in Science Education Award, and describes her professional transformation in this Q&A.